Tracing Spatiotemporal T790M Heterogeneity in Patients with EGFR-Mutant Advanced NSCLC after Acquired Resistance to EGFR TKIs

被引：0
|
作者：
Zhang, Yi-Chen
Pi, Can
Ke, E-E
Chen, Zhi-Hong
Su, Jian
Dong, Zhong-Yi
Xu, Chong-Rui
Tu, Hai-Yan
Yan, Hong-Hong
Zhong, Wen-Zhao
Yang, Jin-Ji
Zhang, Xu-Chao
Wu, Yi Long
Zhou, Qing
机构：
[1] Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
[2] GGH, Guangzhou, Guangdong, Peoples R China
[3] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Acquired resistance; EGFR TKIs; spatiotemporal heterogeneity; T790M;
D O I：
10.1016/j.jtho.2016.11.1762
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02b-095
引用
收藏
页码：S1249 / S1249
页数：1
相关论文
共 50 条
  • [21] A Comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR-TKI resistance
    Wang, Wenxian
    Song, Zhengbo
    Zhang, Yiping
    CANCER MEDICINE, 2017, 6 (01): : 154 - 162
  • [22] Detection of the T790M Mutation of EGFR in Plasma of Advanced NSCLC Patients with Acquired Resistance to EGFR-TKI (WJOG8014LTR)
    Azuma, Koichi
    Takahama, Takayuki
    Sakai, Kazuko
    Takeda, Masayuki
    Hida, Toyoaki
    Hirabayashi, Masataka
    Oguri, Tetsuya
    Tanaka, Hiroshi
    Ebi, Noriyuki
    Sawa, Toshiyuki
    Bessho, Akihiro
    Tachihara, Motoko
    Akamatsu, Hiroaki
    Bandoh, Shuji
    Himeji, Daisuke
    Ohira, Tatsuo
    Shimokawa, Mototsugu
    Yamamoto, Nobuyuki
    Nakanishi, Yoichi
    Nakagawa, Kazuhiko
    Nishio, Kazuto
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S389 - S390
  • [23] Association of plasma EGFR T790M ctDNA status with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance.
    Zheng, Di
    Ye, Xin
    Zhang, Meizhuo
    Sun, Yun
    Wang, Jiying
    Ni, Jian
    Zhang, Haiping
    Zhang, Ling
    Luo, Jie
    Zhang, Jie
    Tang, Liang
    Su, Bo
    Chen, Gang
    Zhu, Guanshan
    Gu, Yi
    Xu, Jianfang
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer: Distinct Natural History of Patients with Tumors Harboring the T790M Mutation
    Oxnard, Geoffrey R.
    Arcila, Maria E.
    Sima, Camelia S.
    Riely, Gregory J.
    Chmielecki, Juliann
    Kris, Mark G.
    Pao, William
    Ladanyi, Marc
    Miller, Vincent A.
    CLINICAL CANCER RESEARCH, 2011, 17 (06) : 1616 - 1622
  • [25] The role of T790M mutation in EGFR-TKI re-challenge for patients with EGFR-mutant advanced lung adenocarcinoma
    Zhang, Qiuyi
    Ke, Ee
    Niu, Feiyu
    Deng, Wei
    Chen, Zhihong
    Xu, Chongrui
    Zhang, Xuchao
    Zhao, Ning
    Su, Jian
    Yang, Jinji
    Yan, Honghong
    Wu, Yilong
    Zhou, Qing
    ONCOTARGET, 2017, 8 (03) : 4994 - 5002
  • [26] Acquired concurrent EGFR T790M and driver gene resistance from EGFR-TKIs hampered osimertinib efficacy in advanced lung adenocarcinoma
    Wu, F.
    Zeng, Y.
    Feng, Y.
    Fu, G.
    Jiang, J.
    Liu, X.
    Pan, Y.
    Hu, C.
    Liu, X.
    ANNALS OF ONCOLOGY, 2022, 33 : S58 - S59
  • [27] Detecting T790M mutation of tissue and plasma ctDNA samples by ARMS in EGFR-mutant NSCLC patients after disease progression
    Wu, Ya-Lan
    Tong, Rui-Zhan
    Zhang, Yan
    Hu, Bin -Bin
    Zhen, Ke
    Zhao, Qian
    Zhou, Xiao-Juan
    Ding, Zhen-Yu
    Peng, Feng
    Gong, You-Ling
    Xu, Yong
    Wang, Jin
    Ren, Li
    Liu, Yong-Mei
    Lu, You
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] Clinical Likelihood of Sporadic Primary EGFR T790M Mutation in EGFR-Mutant Lung Cancer
    Lee, Youngjoo
    Lee, Geon Kook
    Hwang, Jung-Ah
    Yun, Tak
    Kim, Heung Tae
    Lee, Jin Soo
    CLINICAL LUNG CANCER, 2015, 16 (01) : 46 - 50
  • [29] T790M MUTATION ASSOCIATED WITH BETTER EFFICACY OF CONTINUOUS EGFR-TKI TREATMENT IN ADVANCED NSCLC PATIENTS WITH ACQUIRED RESISTANCE TO EGFR-TKI
    Ren, Shengxiang
    Li, Wei
    Li, Aiwu
    Chen, Xiaoxia
    Gao, Guanghui
    He, Yayi
    Li, Xuefei
    Zhou, Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1084 - S1084
  • [30] The Effect of Metformin on Survival Outcomes of Advanced EGFR-mutant NSCLC Patients Treated with EGFR TKIs in Thailand
    Saichaemchan, S.
    Kanjanavithayakul, Y.
    Prasongsook, N.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S484 - S485
12345